AI-generated summary
This randomized controlled trial compared bright light therapy with dim red light as an add-on treatment for acute bipolar depression over two weeks. The authors report that bright light produced a greater improvement in depressive symptoms, with a median onset of about 4.33 days, and no participants switched into hypomania. The study was single blind, with 63 of 74 randomized participants completing it.
- Participants
- 74
- Who or what was studied
- Patients with acute bipolar depression
- Limits stated in the abstract
- The abstract describes a single blind design with attrition from 74 randomized to 63 completers, and it does not report the wavelength or the study's long-term follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Bright light therapy, Randomized controlled trial, Trial registration, Red light therapy, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.